After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Drug Manufacturers – Specialty & Generic industry segment, falling under the Healthcare sector. The current market capitalization of United Therapeutics Corp is $17.70B. A total of 1.68 million shares were traded on the day, compared to an average of 686.76K shares.
In the most recent transaction, CAUSEY CHRISTOPHER sold 3,000 shares of UTHR for 423.21 per share on Sep 02 ’25. After the transaction, the Director now owns 4,865 company shares. In a previous transaction on Sep 02 ’25, Michael Benkowitz bought 112,500 shares at 304.76 per share.
Among the insiders who bought shares, CHRISTOPHER CAUSEY acquired of 3,000 shares on Sep 02 ’25 at a per-share price of $423.21. In another insider transaction, MAHON PAUL A sold 11,000 shares at $308.75 per share on Aug 21 ’25. Company shares held by the EVP & GENERAL COUNSEL now total 36,781.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, UTHR has a high of $436.95 and a low of $266.98.
As of this writing, UTHR has an earnings estimate of $7.07 per share for the current quarter. EPS was calculated based on a consensus of 11.0 estimates, with a high estimate of $8.78 per share and a lower estimate of $6.08. The company reported an EPS of $6.39 in the last quarter
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. UTHR’s latest balance sheet shows that the firm has $1.93B in Cash & Short Term Investments as of fiscal 2021. There were $800.00M in debt and $305.40M in liabilities at the time. Its Book Value Per Share was $158.65, while its Total Shareholder’s Equity was $3.96B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for UTHR is Buy with a score of 4.29.
